IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Strides Agrees on Injectables Deal

8:53 AM MST | November 7, 2007 | Chemical Week Editorial Staff

Pharmaceutical company Strides Arcolab (Bangalore, India) says it has agreed on a deal with pharma manufacturer Sagent Pharmaceuticals (Schaumburg, IL) to jointly develop, supply, and market injectable products for the U.S. market. Strides Arcolab will develop and supply injectable products that Sagent will market in the U.S., under terms of the deal. The agreement will initially target 25 products, the companies say. Sagent is a privately held specialty pharma company that was founded in 2006. “The strength and experience of our sales organization as well...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa